Hematopoietic stem cell mobilization with plerixafor in sickle cell disease

After more than a half-century since the molecular basis for sickle cell disease (SCD) was described by Linus Pauling and colleagues, we now possess the molecular tools to contemplate a one-time cure through genetic modification of autologous hematopoietic stem cells (HSC). For these promising gene